Related Experiment Video
Updated: May 10, 2026
07:28
Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery
Published on: February 3, 2026
Abnormal uterine bleeding in pre-menopausal women
Sukhbir Singh1, Carolyn Best2, Sheila Dunn2
1Ottawa ON.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|June 13, 2013
Summary
Abnormal uterine bleeding (AUB) affects many women, causing a significant health burden. This guideline offers evidence-based strategies for diagnosing and managing AUB, prioritizing patient well-being and least invasive treatments.
Area of Science:
- Reproductive Health
- Gynecology
- Evidence-Based Medicine
Background:
- Abnormal uterine bleeding (AUB) significantly impacts women's health and incurs substantial healthcare costs.
- Affecting up to 30% of women during reproductive years, AUB necessitates updated clinical guidance.
Purpose of the Study:
- To establish current, evidence-based guidelines for diagnosing and managing abnormal uterine bleeding (AUB) in reproductive-aged women.
- To equip healthcare providers with tools for optimal patient care regarding AUB.
Main Methods:
- Systematic literature review of English medical publications from January 1999 to February 2013.
- Inclusion of systematic reviews, RCTs, and observational studies, supplemented by grey literature searches.
- Recommendations developed through expert consensus and approved by the SOGC Executive and Council.
Main Results:
- The guideline summarizes current evidence on AUB diagnosis, investigations, and management options.
- Evaluated outcomes include quality of life impacts and intervention effectiveness (medical and surgical).
- Recommendations are adaptable for individual healthcare providers managing women with AUB.
Conclusions:
- AUB is a common, potentially debilitating condition requiring standardized terminology and a systematic diagnostic approach.
- A step-wise intervention strategy, starting with medical management and progressing to minimally invasive surgery, is recommended.
- The ultimate goal is achieving patient-satisfactory outcomes through appropriate therapeutic interventions.
Related Concept Videos
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
01:18Menses Phase
The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:19The Menstrual Cycle
The menstrual cycle is a recurrent sequence of changes in the uterine endometrium, specifically its functional layer, the stratum functionalis. This cycle prepares the uterus for potential pregnancy. This cycle typically spans 21–35 days, averaging 28 days, and aligns with the ovarian cycle, regulated by fluctuating levels of ovarian hormones, primarily estrogen and progesterone.
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a uterine...
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a uterine...
02:07Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
01:22Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.